That it's stupidly valued along with most spec stocks... Av just got hit the hardest of the ones I know.
Quarterly says BFS mining costs coming in line with PFS, updated designs and harder rock then expected might lead to higher capex? Guess we will see soon, because the SP is just insane, I can't believe it dropped below the crazy 9c raising.
Adak for sale, reducing costs focusing solely on Viscaria to get the project up.
Leases progressing.
We pay Munkton $2xx 000k, but thats pretty much the only large salary so it's not as if the directors are all living lavish lifestyles at our expense.
Even Sweeney had buy orders in at 10c before the 9c raising, but it seems everyone still wants out of specs at whatever pathetic price they can get.. Takes a while for people to get over GFC2, end of world mentalities but hopefully a strong market push into the new year will see some appreciation.
Copper held strong well above the PFS forecasts, but if someone is happy selling their shares at 8c then what can you do but watch and shake your head..
- Forums
- ASX - By Stock
- STM
- results of meeting...
results of meeting..., page-10
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add STM (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.001(14.3%) |
Mkt cap ! $41.19M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.7¢ | $127.6K | 16.04M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
35 | 20867068 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 580000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
35 | 20867068 | 0.007 |
24 | 31954932 | 0.006 |
17 | 7937111 | 0.005 |
19 | 12147891 | 0.004 |
10 | 9585341 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 580000 | 2 |
0.009 | 9773398 | 13 |
0.010 | 10679576 | 13 |
0.011 | 5190999 | 5 |
0.012 | 7100133 | 9 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
STM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online